Effects of low level radiation-what's new?

A comprehensive review of the effects of exposure to low levels of ionizing radiation, BEIR VII-Phase 2: Health Risks From Exposure to Low Levels of Ionizing Radiation, was published in 2006. The BEIR (Biological Effects of Ionizing Radiation) reports are a series of publications by the National Academy of Sciences. The last BEIR report on the effects of low level radiation, BEIR V, was published in 1990. To update the risk estimates for exposure to low levels of ionizing radiation, the BEIR committee reviewed recent epidemiologic studies of the atomic bomb survivors, as well as recent studies of populations exposed to radiation from diagnostic and therapeutic medical studies, from occupational exposures and from exposure due to releases of radioactive materials into the environment. Additional increasingly sophisticated epidemiologic studies continue to be published. BEIR VII reconfirmed that the linear no threshold model is the most practical model to estimate radiation risks, especially for radiation protection purposes. The updated risk estimates have not changed significantly from the BEIR V estimates, but the confidence intervals have narrowed as the result of the availability of additional data. The effects of low doses of radiation should be of particular interest to medical professionals because radiation exposure from diagnostic medical studies is, by far, the largest source of radiation exposure from human activity. One recommendation of the BEIR VII report is to perform epidemiologic studies of patients, especially children, who have been exposed to radiation as part of their care. A large, sophisticated epidemiologic study will likely be able to detect an increase in cancer risk. The purpose of this article is to highlight the contents of this important publication with particular emphasis on what is new.     

Development of radiation protection standards

Radiation protection standards are based on the best available knowledge, caution, and perception. Dose limits for occupational exposure have decreased as knowledge was gained about radiation effects: from 0.6 Sv (60 rem)/year for 1900-1930 to 50 mSv (5 rem)/year in 1958 (the level still used as of 1990). Current dose limits for public exposure range from 1 mSv to 5 mSv, depending on frequency of exposure. For the embryo and fetus, dose limits are 0.5 mSv/mo and 5 mSv for the entire gestation. In the 1970s, the concept of acceptable risk and that of a non-threshold dose-response relationship became the basis for setting dose limits. Three principles of radiation protection are that (a) dose levels should not exceed acceptable levels, (b) optimal dose levels should be as low as reasonably achievable, and (c) radiation should not be used unless it produces a positive net benefit. Although no dose limits have been set for patients undergoing diagnostic and therapeutic radiologic procedures, such measures must provide a net benefit to patients at optimal dose levels.     

Dose-response models and methods of risk prediction and causation estimation

Dose-response models are mathematical expressions that describe the relationship between absorbed dose and radiogenic effects. The limited quality and quantity of human dose-response data make it necessary to use fairly simplistic models. Most current low-LET data support the linear-quadratic model in which radiogenic effects are linearly dependent at low doses and then become quadratically curved at higher doses. Some types of effects never exhibit a quadratic component, remaining linear over a wide range of absorbed dose. Future progress in developing more refined dose-response models is more likely to come from a better understanding of the fundamentals of radiation carcinogenesis rather than better data or better curve-fitting techniques. The risk of radiation injury is a prospective estimation of the probability that some harm will result in the future as a consequence of having been irradiated. Quantitative risk estimates for the carcinogenic, genetic, and fetal effects of low level radiation that have been determined by national and international organizations are of the order of magnitude of one chance fatality in 10,000/rem. Causation estimation is the retrospective analysis of the probability that cancer observed in an irradiated individual was caused by radiation as opposed to some other agent. Depending on the dose type of cancer, gender, age at time of irradiation, and time since irradiation, the probability of causation can range from 0% to 100%. Methods for calculation of the probability of causation for certain types of cancer and irradiation circumstances have been developed recently by the National Institutes of Health.     

Health Effects from Occupational Radiation Exposure among Fluoroscopy-Guided Interventional Medical Workers: A Systematic Review

A systematic review was conducted to provide an overview of the health effects of occupational radiation exposure from interventional fluoroscopy procedures on medical radiation workers. Among the 34 studies that met the inclusion criteria, most studies were cross-sectional (76%) and published after 2011 (65%) in a handful of countries. Although diverse outcomes were reported, most studies focused on cataracts. Radiation health effects were rarely assessed by risk per unit dose. Interventional radiation medical workers represent a small subset of the population studied worldwide. Further epidemiologic studies should be conducted to evaluate health outcomes among interventional radiation medical workers.     

Hormesis,an update of the present position

The ongoing debate over the possible beneficial effects of ionising radiation on health, hormesis, is reviewed from different perspectives. Radiation hormesis has not been strictly defined in the scientific literature. It can be understood as a decrease in the risk of cancer due to low-dose irradiation, but other positive health effects may also be encompassed by the concept. The overwhelming majority of the currently available epidemiological data on populations exposed to ionising radiation support the assumption that there is a linear non-threshold dose-response relationship. However, epidemiological data fail to demonstrate detrimental effects of ionising radiation at absorbed doses smaller than 100-200 mSv. Risk estimates for these levels are therefore based on extrapolations from higher doses. Arguments for hormesis are derived only from a number of epidemiological studies, but also from studies in radiation biology. Radiobiological evidence for hormesis is based on radio-adaptive response; this has been convincingly demonstrated in vitro, but some questions remain as to how it affects humans. Furthermore, there is an ecologically based argument for hormesis in that, given the evolutionary prerequisite of best fitness, it follows that humans are best adapted to background levels of ionising radiation and other carcinogenic agents in our environment. A few animal studies have also addressed the hormesis theory, some of which have supported it while others have not. To complete the picture, the results of new radiobiological research indicate the need for a paradigm shift concerning the mechanisms of cancer induction. Such research is a step towards a better understanding of how ionising radiation affects the living cell and the organism, and thus towards a more reliable judgement on how to interpret the present radiobiological evidence for hormesis.     

Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamine

Positron emission tomographic (PET) scanning after systemic i.v. injection of fluorine-18-6-fluorodopamine ([18F]-6F-DA) is a method for visualizing and measuring regional sympathetic nervous system innervation and function. Based on results of preclinical studies of rats and dogs and on previous literature about the fate of injected tracer-labeled catecholamines, dosimetric estimates for clinical studies are presented here. After injection of 1 mCi of [18F]-F-DA, the radiation dose would be highest to the wall of the urinary bladder (1.40 rem/mCi), due to accumulation of radioactive metabolites of [18F]-F-DA in urine. Radioactivity also would accumulate in bile. Organs receiving the next highest dose would be the kidneys (0.9 rem/mCi) and small intestine (0.2 rem/mCi). The parenchymal radiation dose would be lowest in the brain, since there is an effective blood-brain barrier for circulating catecholamines. Radiation doses to all organs after administration of 1 mCi of [18F]-F-DA to humans would be less than 3 rem and, therefore, within current FDA guidelines.     

Radiation dose in defecography

The effective dose equivalent, as an expression of total patient risk for exposure to limited areas of the body, and gonadal doses associated with hereditary effects were estimated in 67 consecutive subjects (43 women and 24 men) who underwent defecography. With use of measured entrance exposure values and data from Monte Carlo simulations, the mean effective dose equivalent was estimated at 4.9 mSv +/- 1.6 (490 mrem +/- 160) for women and 0.6 mSv +/- 0.2 (60 mrem +/- 20) for men. The ovarian dose was 15 mSv +/- 5 (1.5 rem +/- 0.5). The testes are not within the primary beam and therefore are exposed to scattered radiation only, hence the low received dose of 0.14 mSv or less (14 mrem or less). These data indicate that defecography is among the radiologic procedures associated with a considerable, but not extreme, radiation dose.     

A composite microdose Adaptive Response (AR) and Bystander Effect (BE) model-application to low LET and high LET AR and BE data

PURPOSE: It has been suggested that Adaptive Response (AR) may reduce risk of adverse health effects due to ionizing radiation. But very low dose Bystander Effects (BE) may impose dominant deleterious human risks. These conflicting behaviors have stimulated controversy regarding the Linear No-Threshold human risk model. A dose and dose rate-dependent microdose model, to examine AR behavior, was developed in prior work. In the prior work a number of in vitro and in vivo dose response data were examined with the model. Recent new data show AR behavior with some evidence of very low dose BE. The purpose of this work is to supplement the microdose model to encompass the Brenner and colleagues BaD (Bystander and Direct Damage) model and apply this composite model to obtain new knowledge regarding AR and BE and illustrate the use of the model to plan radio-biology experiments. MATERIALS AND METHODS: The biophysical composite AR and BE Microdose Model quantifies the accumulation of hits (Poisson distributed, microdose specific energy depositions) to cell nucleus volumes. This new composite AR and BE model provides predictions of dose response at very low dose BE levels, higher dose AR levels and even higher dose Direct (linear-quadratic) Damage radiation levels. RESULTS: We find good fits of the model to both BE data from the Columbia University microbeam facility and combined AR and BE data for low Linear Energy Transfer (LET) and high LET data. A Bystander Factor of about 27,000 and an AR protection factor of 0.61 are obtained for the low LET in vivo mouse spleen exposures. A Bystander Factor of 317 and an AR protection factor of 0.53 are obtained for high LET radon alpha particles in human lymphocytes. In both cases the AR is activated at most by one or two radiation induced charged particle traversals through the cell nucleus. CONCLUSIONS: The results of the model analysis is consistent with a premise that both Bystander damage and Adaptive Response radioprotection can occur in the same cell type, derived from the same cell species. The model provides an analytical tool to biophysically study the combined effects of BE and AR.     

Can radiation research impact the estimation of risk?

Abstract

Purpose: This review is a contribution to the memory of Dr William (Bill) Morgan and highlights an area of research and deliberation that he considered extremely important in support of the setting of protective radiation dose limits. Biological research has generally played a minor role in the estimation of adverse health outcomes following exposure to low doses and low dose rates of radiation. The reliance has been on the available, quite extensive data base of epidemiology studies. The major concern is that such studies are for moderate to high doses requiring risk extrapolation methodologies for estimating low dose effects. There are significant uncertainties associated with this approach. This review will discuss how radiation biology studies can potentially reduce this uncertainty through the use of a key events/adverse outcome pathways approach to identify bioindicators of cancer and non-cancer effects for use as parameters in biologically-based dose-response (BBDR) models. Such models would allow for an improved extrapolation approach for estimating health effects at low doses and low dose rates of radiation.

Conclusion: Based on reported and ongoing studies for environmental chemicals, the adverse outcome/key events approach is a viable one for enhanced risk assessment (and risk management practice). The identification of informative bioindicators of adverse health effects will be a challenge but with modern molecular and advanced computational techniques, it is certainly feasible. This approach provides a framework for defining a low dose radiation research program; something that was of great importance to Bill Morgan.     

Late health effects of radiation exposure: New statistical,epidemiological, and biological approaches*

Abstract

Purpose: The 2012 Conference on Radiation and Health in Kennebunkport, Maine, USA, brought together epidemiologists, statisticians, basic scientists, and clinical scientists interested in the health effects of radiation exposure due to medical, diagnostic, occupational, and non-medical sources, to review the current status of epidemiologic and clinical research on radiation exposure in relation to risk of breast, thyroid cancer, and leukemia, cardiopulmonary events, and other late effects. Topics discussed included synergy between radiation exposure and genetic background; late effects of radiation therapy in childhood cancer survivors and several other medically exposed cohorts; leukemia risk seen in Russian and Chernobyl studies, and leukemia risk from computed tomography scans in childhood.

Results and conclusions: This report summarizes the presentations at the meeting and discusses their significance in light of earlier studies and of other ongoing research.     

Radiation Dose, Reproductive History, and Breast Cancer RiskAmong Japanese A-Bomb Survivors: Preliminary Results

Excess risk of female breast cancer is among the most comprehensively documented late cfleets Of exposure to substantial doses of ionizing radiation,based on studies of medically irradiated populations and the survivors of the atomic bombings of Hiroshima and Nagasaki,Japan. Relatively little is known about the joint cfleets ot radiation dose with other breast cancer risk factors.     

Radiation dose measurement and risk estimation for paediatric patients undergoing micturating cystourethrography

Micturating cystourethrography (MCU) is considered to be the gold-standard method used to detect and grade vesicoureteric reflux (VUR) and show urethral and bladder abnormalities. It accounts for 30-50% of all fluoroscopic examinations in children. Therefore, it is crucial to define and optimize the radiation dose received by a child during MCU examination, taking into account that children have a higher risk of developing radiation-induced cancer than adults. This study aims to quantify and evaluate, by means of thermoluminescence dosimetry (TLD), the radiation dose to the newborn and paediatric populations undergoing MCU using fluoroscopic imaging. Evaluation of entrance surface dose (ESD), organ and surface dose to specific radiosensitive organs was carried out. Furthermore, the surface dose to the co-patient, i.e. individuals helping in the support, care and comfort of the children during the examination, was evaluated in order to estimate the level of risk. 52 patients with mean age of 0.36 years who had undergone MCU using digital fluoroscopy were studied. ESD, surface doses to thyroid, testes/ovaries and co-patients were measured with TLDs. MCU with digital equipment and fluoroscopy-captured image technique can reduce the radiation dose by approximately 50% while still obtaining the necessary diagnostic information. Radiographic exposures were made in cases of the presence of reflux or of the difficulty in evaluating a finding. The radiation surface doses to the thyroid and testes are relatively low, whereas the radiation dose to the co-patient is negligible. The risks associated with MCU for patients and co-patients are negligible. The results of this study provide baseline data to establish reference dose levels for MCU examination in very young patients.     

Cardiac-CT with the newest CT scanners: An incoming screening tool for competitive athletes?

Competitive athletes of all skill levels are at risk of sudden cardiac death (SCD) due to certain heart conditions. Prior to engagement in high-intensity athletics, it is necessary to screen for these conditions in order to prevent sudden cardiac death. Cardiac-CT angiography (CCTA) is a reliable tool to rule out the leading causes of SCD by providing an exceptional overview of vascular and cardiac morphology. This allows CCTA to be a powerful resource in identifying cardiac anomalies in selected patients (i.e. unclear symptoms or findings at ECG or echocardiography) as well as to exclude significant coronary artery disease (CAD). With the advancement of technology over the last few years, the latest generations of computed tomography (CT) scanners provide better image quality at lower radiation exposures. With the amount of radiation exposure per scan now reaching the sub-millisievert range, the number of CT examinations it is supposed to increase greatly, also in the athlete's population. It is thus necessary for radiologists to have a clear understanding of how to make and interpret a CCTA examination so that these studies may be performed in a responsible and radiation conscious manner especially when used in the younger populations. Our work aims to illustrate the main radiological findings of CCTAs and highlight their clinical impact with some case studies. We also briefly describe critical features of state-of-the-art CT scanners that optimize different acquisitions to obtain the best quality at the lowest possible dose.     

心血管病介入操作时患者受照剂量估算

放射诊疗新技术给人类带来了巨大的利益,放射性介入操作是其中最具代表性的一类新技术.然而在放射性介入操作的过程中,患者受照剂量在医用X射线诊断和治疗中是最高的,其剂量可能大到能引起皮肤和眼晶体辐射损伤,而且其防护也是目前职业辐射防护中最困难的.目前有60%左右的介入术是在心血管病的治疗中开展,心血管病介入操作时患者的辐射防护问题已引起了国内外广泛的重视,并开展了较为广泛的研究.大量的研究结果表明,心血管病放射性介入操作可能给患者造成值得重视的高剂量辐射.但是许多研究都是集中在表面剂量,这个量对评估患者的风险是远远不够的.在外照射情况下,当人体受穿透力强的辐射(X射线、γ射线、中子)照射一定剂量时,可造成深部组织和器官损伤,因此在研究表面剂量的同时,研究深部组织和器官的剂量也是至关重要的.由于放射性介入操作可能引起肿瘤和遗传这类随机性效应损伤,因此需要估算其有效剂量.     

Overview of radiation-induced skin cancer in humans

There are about a dozen studies of the incidence of skin cancer among irradiated populations with known skin doses that are available for estimating the risk of radiation-induced skin cancer. It is of note that they provide no evidence for a dose threshold and are compatible with a linear dose-response relationship, at least for ultraviolet radiation exposed skin. The studies also provide varying amounts of evidence concerning a number of other important issues in assessing skin cancer risk: types of skin cancer induced by ionizing radiation, the appropriateness of relative risk vs absolute risk models, combined effects of ionizing and UV radiations, and variations in sensitivity to skin cancer induction among demographic and genetic subgroups. Little epidemiological information is available on several factors, such as the RBE for high-LET radiation, the effects of dose protraction or fractionation, or variations in risk by age at irradiation. A reasonable estimate of skin cancer lethality was 0.2 per cent when weighted for the relative proportions of squamous cell and basal cell skin cancers. Average risk estimates of radiation-induced skin cancer incidence were: absolute risk (AR) of 8.5 X 10(-4) person-year-Sv and excess relative risk (RR) of 52 per cent/Sv. Lifetime skin cancer risk was calculated by life-table methods for males from exposures spread out over ages 20-60 years. The estimates for excess skin cancer incidence were 2 per cent and 11 per cent per Sv under the AR and RR models, respectively, while the corresponding mortality risks were 4 X 10(-5) and 2 X 10(-4) per Sv.     

Radiation risk of tissue late effects, a net consequence of probabilities of various cellular responses

Late effects from the exposure to low doses of ionizing radiation are hardly or not at all observed in man probably due to the low values of risk coefficients that preclude statistical analyses of data from populations that are exposed to doses less than 0.2 Gy. In order to arrive at an assessment of potential risk from radiation exposure in the low dose range, the microdosimetry approach is essential. In the low dose range, ionizing radiation generates particle tracks, mainly electrons, which are distributed rather heterogenously within the exposed tissue. Taking the individual cell as the elemental unit of life, observations and calculations of cellular responses to being hit by energy deposition events from low LET type are analysed. It emerges that besides the probability of a hit cell to sustain a detrimental effect with the consequence of malignant transformation there are probabilities of various adaptive responses that equip the hit cell with a benefit. On the one hand, an improvement of cellular radical detoxification was observed in mouse bone marrow cells; another adaptive response pertaining to improved DNA repair, was reported for human lymphocytes. The improved radical detoxification in mouse bone marrow cells lasts for a period of 5-10 hours and improved DNA repair in human lymphocytes was seen for some 60 hours following acute irradiation. It is speculated that improved radical detoxification and improved DNA repair may reduce the probability of spontaneous carcinogenesis. Thus it is proposed to weigh the probability of detriment for a hit cell within a multicellular system against the probability of benefit through adaptive responses in other hit cells in the same system per radiation exposure. In doing this, the net effect of low doses of low LET radiation in tissue with individual cells being hit by energy deposition events could be zero or even beneficial. Since there was no simple additivity of equal effects from repeated exposures to equal doses and because of the potential effect of adaptive cell responses on the spontaneous evolution of malignancy in tissue, the extrapolation of risk with absorbed dose reaching down to zero, does not appear to be generally valid.     

Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI

"When one admits that nothing is certain one must, I think, also admit that some things are much more nearly certain than others." Bertrand Russell (1872-1970) Computed tomography (CT) is one of the largest contributors to man-made radiation doses in medical populations. CT currently accounts for over 60 million examinations in the United States, and its use continues to grow rapidly. The principal concern regarding radiation exposure is that the subject may develop malignancies. For this systematic review we searched journal publications in MEDLINE (1966-2006) using the terms "CT," "ionizing radiation," "cancer risks," "MRI," and "patient safety." We also searched major reports issued from governmental U.S. and world health-related agencies. Many studies have shown that organ doses associated with routine diagnostic CT scans are similar to the low-dose range of radiation received by atomic-bomb survivors. The FDA estimates that a CT examination with an effective dose of 10 mSv may be associated with an increased chance of developing fatal cancer for approximately one patient in 2000, whereas the BEIR VII lifetime risk model predicts that with the same low-dose radiation, approximately one individual in 1000 will develop cancer. There are uncertainties in the current radiation risk estimates, especially at the lower dose levels encountered in CT. To address what should be done to ensure patient safety, in this review we discuss the "as low as reasonably achievable" (ALARA) principle, and the use of MRI as an alternative to CT.     

Radiation risk of tissue late effects,a net consequence of probabilities of various cellular responses

Late effects from the exposure to low doses of ionizing radiation are hardly or not at all observed in man probably due to the low values of risk coefficients that preclude statistical analyses of data from populations that are exposed to doses less than 0.2 Gy. In order to arrive at an assessment of potential risk from radiation exposure in the low dose range, the microdosimetry approach is essential. In the low dose range, ionizing radiation generates particle tracks, mainly electrons, which are distributed rather heterogenously within the exposed tissue. Taking the individual cell as the elemental unit of life, observations and calculations of cellular responses to being hit by energy deposition events from low LET type are analysed. It emerges that besides the probability of a hit cell to sustain a detrimental effect with the consequence of malignant transformation there are probabilities of various adaptive responses that equip the hit cell with a benefit. On the one hand, an improvement of cellular radical detoxification was observed in mouse bone marrow cells; another adaptive response pertaining to improved DNA repair, was reported for human lymphocytes. The improved radical detoxification in mouse bone marrow cells lasts for a period of 5–10 hours and improved DNA repair in human lymphocytes was seen for some 60 hours following acute irradiation. It is speculated that improved radical detoxification and improved DNA repair may reduce the probability of spontaneous carcinogenesis.Thus it is proposed to weigh the probability of detriment for a hit cell within a multicellular system against the probability of benefit through adaptive responses in other hit cells in the same system per radiation exposure. In doing this, the net effect of low doses of low LET radiation in tissue with individual cells being hit by energy deposition events could be zero or even beneficial. Since there was no simple additivity of equal effects from repeated exposures to equal doses and because of the potential effect of adaptive cell responses on the spontaneous evolution of malignancy in tissue, the extrapolation of risk with absorbed dose reaching down to zero, does not appear to be generally valid.     

急性核辐射对人的远期效应

内容仅涉及事故性急性核辐射的远期效应:1.日本原爆幸存者(包括宫内受照者约2800名)的流行病学调查结果,归纳为强关联、弱关联和无关联的远期效应。在第8～15孕周阶段接受1Gy照射的胎儿,约有43%会发生智力发育延迟,为受照0.01Gy以下的对比组危险度的50倍以上。对原爆人群各部位癌症的相对、绝对和归因危险作了介绍。对原爆幸存者受照射后怀孕所生子女(1946年5月以后出生),用(1)不利的妊娠结果、(2)死亡事件、(3)携带有性染色体异常儿童的频率、(4)携有由于基因突变引起的血液蛋白电泳变异体儿童的频率等遗传学指标提示,近爆心(<2000m)幸存者(>1Gy)所生儿童与远离爆心组(0.01～0.09Gy)相比,仅仅是预期趋势上有差别,实际上未发现有统计学意义的差异。即使如此,这两组儿童间的差异用上述4个指标中的前3个观察结果,估计了加倍剂量,平均数是1.56Sv,但是有争议。2.马绍尔群岛放射性落下灰受照居民医学随访近况,甲状腺疾病发病率高,而在日本原爆幸存者中则未见类似情况,估计与马绍尔群岛居民甲状腺因摄入放射性碘而照射量较大有关。3.日本福隆丸号渔民受落下灰照射后远后效应资料。4.美国Y-12工厂共8名受照者的远后效应:4例有放射性白内障,1998年时仅活存3例。5.前苏联切尔诺贝利核电站事故中急性放射病(ARS)病人远后效应:2例Ⅲ度ARS病人分别于照后第6年和第9年发生骨髓增生异常综合征(MDS)引起死亡,1例Ⅰ度ARS病人也于照后第9年诊断为MDS,另一例Ⅱ度ARS病人照后第11年发生急性单核细胞白血病。6.巴西137Cs事故5年后远期效应。     

Overview of Radiation-induced Skin Cancer in Humans

Summary

There are about a dozen studies of the incidence of skin cancer among irradiated populations with known skin doses that are available for estimating the risk of radiation-induced skin cancer. It is of note that they provide no evidence for a dose threshold and are compatible with a linear dose–response relationship, at least for ultraviolet radiation exposed skin. The studies also provide varying amounts of evidence concerning a number of other important issues in assessing skin cancer risk: types of skin cancer induced by ionizing radiation, the appropriateness of relative risk vs absolute risk models, combined effects of ionizing and UV radiations, and variations in sensitivity to skin cancer induction among demographic and genetic subgroups. Little epidemiological information is available on several factors, such as the RBE for high-LET radiation, the effects of dose protraction or fractionation, or variations in risk by age at irradiation. A reasonable estimate of skin cancer lethality was 0·2 per cent when weighted for the relative proportions of squamous cell and basal cell skin cancers. Average risk estimates of radiation-induced skin cancer incidence were: absolute risk (AR) of 8·5 × 10^?4 person-year-Sv and excess relative risk (RR) of 52 per cent/Sv. Lifetime skin cancer risk was calculated by life-table methods for males from exposures spread out over ages 20–60 years. The estimates for excess skin cancer incidence were 2 per cent and 11 per cent per Sv under the AR and RR models, respectively, while the corresponding mortality risks were 4 × 10^?5 and 2 × 10^?4 per Sv.